Only three proteins, DNAJB1, DDX3X, and Bruton tyrosine kinase (BTK), were found to be decreased in all CD5-positive DLBCL cases compared to CD5-negative DLBCL cases. The gene discussed is BTK; the disease is diffuse large B-cell lymphoma.